Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation

NCT ID: NCT02501577

Last Updated: 2015-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Placement of a supraglottic airway device Fiberoptical verification of pharyngeal position

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Feasibility for fiberoptical verification of pharyngeal position of supraglottic airway device

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation; Difficult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SAD 1

FOI for placement

Group Type EXPERIMENTAL

SAD 1

Intervention Type DEVICE

Placement and fiberoptic control

SAD 2

FOI für placement

Group Type EXPERIMENTAL

SAD 2

Intervention Type DEVICE

Placement and fiberoptic control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SAD 1

Placement and fiberoptic control

Intervention Type DEVICE

SAD 2

Placement and fiberoptic control

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* will to participate

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Regensburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Metterlein

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Metterlein, MD

Role: STUDY_CHAIR

Uni Regensburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Regensburg

Regensburg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Metterlein, MD

Role: CONTACT

+499419440

Christoph Plank, MD

Role: CONTACT

+499419440

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Metterlein, MD

Role: primary

+499419440

Christoph Plank, MD

Role: backup

+499419440

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sadfoi

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.